A double blind study of 44 patients (24 placebo, 20 cimetidine) was undertaken to determine the effect of cimetidine on the pH and volume of gastric fluid during anaesthesia. The pH was significantly higher on cimetidine-treated patients than placebo-treated patients at 0, 15, 30 and 45 minutesfollowing intubation. At induction of anaesthesia, mean pH on cimetidine was 4.5 and on placebo mean pH was 2.0. Approximately 70% of patients on cimetidine and 20% on placebo recorded a pH above 2.5 during anaesthesia. The reason for a pH recording of less than 2.5 in seven patients on cimetidine could not be ascertained. Mean volume of gastric aspirate was slightly lower in the cimetidine group at 0, 15, 30 and 45 minutes, but the differences were not significant.
Cimetidine is a non-thiourea competitive H2 receptor antagonist which inhibits gastric acid secretion,1 and has been extensively studied in disorders of the upper gastrointestinal tract. 2 It has no effect on gastric emptying 3 or the lower oesophageal sphincter. 4,5 Given preoperatively it may help prevent the pulmonary complications of acid aspiration" which are still a major cause of anaesthetic related morbidity and mortality. 7,H From animal studies the critical pH and volume of aspirated fluid which cause significant damage have been estimated to be 2.5 and 0.4 mllkg body weight respectively.9
Antacids are the main method of altering the pH but their effectiveness, together with the effects of aspiration of antacid treated gastric fluid have recently been questioned. 7 ,8,1O,11 There are increasing reports looking at the use of cimetidine in preparing patients for *M.H., Ch.B., Dlp.Oh.,., <\.naesthetil: Rl surgery. 12, 13, 14, 15, 16, 17 ,IH In general, cimetidine has been shown to raise the pH of gastric fluid and in some studies a decrease in volume of gastric fluid has been noted.
This study evaluates a further regime using preoperative oral cimetidine. METHOD The study was approved by the appropriate ethics committees and informed consent obtained.
Fifty patients in the 18 to 60 year age range presenting for elective surgery requiring endotracheal intubation were studied. Those with significant disease, receiving medication or having emergency or upper abdominal surgery were excluded.
At 2100 hours the evening prior to surgery the patients received either two tablets of cimetidine 200 mg or two placebo tablets. The drugs were supplied in numbered, sealed containers which had been randomly assigned to the treatment or control groups. Both the patients and the investigators were "blind".
On the morning of surgery they received the remammg tablets from the container, either two 200 mg cimetidine tablets or two placebo tablets, together with a 10 mg diazepam tablet and 20 ml of water approximately one hour before expected induction. The patients received atropine 0.6 mg intravenously at induction, and anaesthesia was induced with thiopentone. Intubation took place with suxamethonium, gallamine, alcuronium or pancuronium, and the patients were all maintained with nItrous oxide/oxygen and intermittent positive pressure ventilation supplemented with a narcotic.
A Salem sump tube was passed into the stomach as soon as practicable after induction and the time, volume and pH of the fluid aspirated by syringe was noted. The tube was manipulated in an effort to obtain as much gastric fluid as possible and aspiration continued at 15 minute intervals throughout the operation. At the end of the operation the tube was removed before reversal of neuromuscular blockade and endotracheal extubation. Pulse and blood pressure were monitored throughout the operation and recovery period.
The pH of the gastric fluid was measured in theatre on a Heath Servo Digital pH/Voltmeter EU 302A, which was calibrated using standard buffer solutions at pH 4.0 and 7.0.
Cases discarded from analysis.
Code Reason 02
No gastric juice obtainedfailed intubation 05
No gastric juice obtained 10
No gastric juice obtained 33
No gastric juice obtained 47
Case cancelled 06
No gastric juice obtained
RESULTS
Of 50 patients who entered the trial, 44 (39 female and five male) were included in the analysis; 20 patients received cimetidine and 24 received placebo. Six patients were not included in the analysis (Table 1 ) and in cases 5, 10 and 33 it is possible that cimetidine caused the lack of gastric aspirate.
The preponderance of females was because they provided the greater pool of suitable subjects. Most patients were undergoing major gynaecological surgery or laparoscopy while the remainder were having a variety of general surgical procedures. Table 2 shows the mean age, mean weight, and mean interval between premedication and induction in the two groups. All patients received thiopentone and atropine for induction while intubation took place with alcuronium in 34 cases, pancuronium in nine, suxamethonium in six, and gallamine in three.
pH of Gastric Contents
Patients on cimetidine had significantly higher values of mean pH at 0, 15, 30 and 45 minutes following induction (Table 3 ).
In the first 30 minutes following induction, 69-751170 of patients on cimetidine and 13-22% on placebo recorded a pH of above 2.5 during anaesthesia (Table 4) . Table 5 compares details of seven patients on cimetidine who recorded pH values of 2.5 or less (group A), with the remaining 13 patients on cimetidine who recorded pH greater than 2.5 throughout anaesthesia (group B). Of group A, five patients had a pH of 2.5 or less on induction of anaesthesia, and the other two developed a pH of 2.5 or less at 30 minutes. On comparing group A and group B there was no significant difference in sex, age, or weight.
Evening and morning cimetidine tablets, last evening meal, and last fluid were taken at almost the same time before intubation in both groups. All patients in group A recorded their low pH while within the four hour period of cimetidine action. Table 6 shows volumes of gastric juice aspirated. Volume in the cimetidine group was less than in the placebo group at 0, 15, 30 and 45 minutes, but the differences were not statistically significant (Student's "t" test). 
Volume of Gastric Contents

Safety Monitoring
No changes in vital signs (blood pressure and pulse rate) during operation or in recovery room were considered drug related. No adverse reactions due to the trial drug were encountered.
DISCUSSION
The problems of Mendelson's syndrome do not appear to have been solved by antacids as deaths still OCCUr. 19 ,1O Hutchinson 20 found a reduction in the incidence, but not in the death rate following the introduction of routine preoperative antacid. Such studies involve large numbers of cases before a true indication is obtained. A continued awareness of the problem is needed, together with alternative methods of prevention both to raise the pH and reduce gastric fluid volume.
This study confirms the findings of other studies of cimetidine in relation to anaesthesia. The administration of a dose of cimetidine the evening prior to surgery is supported by the finding of Longstreth, Go and Malagelada 21 when an evening dose markedly reduced nocturnal acid secretion for five to seven hours. However, their patients suffered from duodenal ulcers. Stoelting 14 found that a single dose of cimetidine the night before surgery elevated the pH above 2.5 in 78OJo of cases. The protocol used in our study would be confined to elective cases although a single preoperative dose has also been found to be effective 16 ,13 and this might be applicable to emergency anaesthesia. In these patients however, cimetidine will have no effect on the pH of existing gastric secretions or food particles which are also implicated in Mendelson's syndrome. 8 The combined use of cimetidine with metoclopramide to enhance gastric emptying may be useful in such cases. 22 Initial reports of cimetidine in obstetric patients are encouraging, with no adverse effects noted on the course of labour or the foetus. 23, 24 A significant group (25%) in this study had a low pH despite cimetidine, and Coombs et al. 16 found this in a similar percentage of their treated group. These patients are still at risk. They attributed this failure to younger patients receiving less than 4.05 mg/kg bodyweight of cimetidine. Our patients still at risk were not the youngest and the dose exceeded this value; therefore other factors must also be present. The bio-availability of an oral dose is 70%25 but this may differ in this group of patients for TABLE 4 Number oJ patients with pH > 2.5 during anaesthesia. some reason. Measurement of blood levels may help to determine this. An oral dose of cimetidine produces peak blood levels at 60-90 minutes,26 and this fits with most schedules for premedication administration. The duration of effect under anaesthesia is not known and in none of our cases did surgery take more than 1 Yz hours. Coombs et al. 16 found that a pH of 2.5 or more was maintained for three hours at least, while in ulcer patients the duration of effect was five to seven hours. 26 A major disadvantage with this method of sampling gastric fluid is the difficulty in ensuring complete emptying of the stomach. Cimetidine reduces the volume of gastric secretions. 26 ,27 This has not been confirmed by our study or others using anaesthetised patients. 16 data. Some recommend converting to H+ ion concentrations before analysis I9 ,2o,21 but Feinstein 22 suggests using pH data unchanged: we did the latter. Cimetidine has been extensively studied for side effects, and following short term treatment the side effects were similar to those in a placebo treated group.26 Some longer term complications include minor elevations in serum creatinine, gynaecomastia, mental confusion, and reversible drug induced liver disease. 26 . 32 We observed no side effects in our group of patients. With present knowledge of the safety of cimetidine, patients would not be exposed to any added risk from a short course of cimetidine in relation to anaesthesia.
